Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Surgery is currently the standard treatment for spinal dural arteriovenous fistulae (DAVF). Endovascular embolisation of these lesions using N-butyl cyanoacrylate (NBCA) has a high success rate. Onyx is a new liquid embolic agent whose viscosity makes it suitable for treatment of spinal DAVF where penetration into the proximal radicular vein is required. It is delivered with greater control than NBCA without the necessity for rapid withdrawal of the catheter and may therefore overcome some of the drawbacks of NBCA. We report two patients who underwent Onyx embolisation of spinal DAVF; to our knowledge this is the first such report.

Original publication

DOI

10.1007/s00234-002-0936-2

Type

Journal article

Journal

Neuroradiology

Publication Date

02/2003

Volume

45

Pages

110 - 112

Keywords

Angiography, Central Nervous System Vascular Malformations, Dimethyl Sulfoxide, Embolization, Therapeutic, Humans, Injections, Male, Middle Aged, Polyvinyls, Spinal Cord, Spinal Cord Diseases